Halitosis Devised Questionnaire Evaluating a New Treatment
NCT01046812
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Halitosis
Interventions
DRUG:
Caphosol
Sponsor
New York Head & Neck Institute